<DOC>
	<DOCNO>NCT02531880</DOCNO>
	<brief_summary>Background : - The blood-brain barrier separate brain rest body . Epilepsy neurological disease cause seizure . It affect barrier . Researchers think contrast agent call mangafodipir might well able show area brain epilepsy affect . Objective : - To see mangafodipir well tolerated safe . To see show , MRI , area brain epilepsy affect . Eligibility : - People age 18-60 : - Have epilepsy control drug - Are enrol protocol 01-N-0139 - Healthy volunteer Design : - Participants screen : - Medical history - Physical exam - Blood urine test - Participants 6 visit 1 3 month . Those epilepsy inpatient stay last 2 10 day . Visits may include : - Video-EEG monitoring participant epilepsy ( healthy volunteer ) - An IV catheter put place : needle guide thin plastic tube arm vein . - Getting mangafodipir IV . - 5 MRI scan 10-day period : magnetic field radio wave take picture brain . Participants lie table slide metal cylinder . They cylinder 45 90 minute , lie still 10 minute time . The scanner make loud knock sound . Participants get earplug . - A final MRI least 2 week receive mangafodipir . Gadolinium give IV catheter .</brief_summary>
	<brief_title>Investigation Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging Drug-Resistant Epilepsy</brief_title>
	<detailed_description>Objective : The primary goal pilot study determine ( 1 ) administration mangafodipir well tolerate healthy volunteer patient epilepsy ( 2 ) peri-ictal administration allow focal entry mangafodipir blood-brain-barrier manganese enhance magnetic resonance imaging ( MEMRI ) visualization seizure focus . Secondary objective exploration MEMRI property patient epilepsy comparison healthy volunteer . Study population : 16 patient drug-resistant epilepsy , 16 healthy control . Design : Screening enrol participant include medical history , physical exam , blood urine laboratory test . Patients healthy volunteer image interictally gadolinium enhance MRI session . For patient , administration mangafodipir do inpatient long-term video EEG recording , ensure administration peri-ictal period . Patients control receive baseline MRI scan , iv mangafodipir injection serially scan non-contrast MRI scan . Outcome measure : The primary outcome ( 1 ) clinical safety parameter mangafodipir administration , ( 2 ) difference T1-weighted signal intensity brain measure mangafodipir administration seizure onset zone identified standard clinical , EEG , image study , homologous contralateral region .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Drug Resistant Epilepsy</mesh_term>
	<mesh_term>Manganese</mesh_term>
	<criteria>INCLUSION CRITERIA : HEALTHY VOLUNTEER : Age 1860 Able give write informed consent directly . PATIENTS : Age 1860 . Able give write informed consent directly . Drug resistant epilepsy participant define clinically document seizure consistent EEG evidence define 1981 International Classification Epileptic Seizures , refractory standard antiseizure treatment least one year prior enrol study average least one seizure per month . This criterion establish preliminary screening NINDS Clinical Epilepsy Section outpatient clinic protocol 01N0139 , necessary , inpatient video EEG monitoring . Seizure focus localization determine standard clinical , neurophysiologic , image study . Prior concurrent enrollment 01N0139 require . EXCLUSION CRITERIA : HEALTHY VOLUNTEER : No current history neurological disease , include epilepsy multiple sclerosis Same exclusion criterion patient PATIENTS : General exclusion : A history drug alcohol abuse/dependence History brain disease epilepsy . Known cause seizure , mesial focal sclerosis , tumor infection . Positive test HIV . History postictal psychosis postictal aggression Brain abnormality brain tumor , stroke , brain damage head trauma blood vessel abnormality , MRI scan . Pregnancy breastfeed . Planning get pregnant next 2 month Claustrophobia degree subject would feel uncomfortable MRI machine . Can lie back least two hour . Risk MRI scan , ( e.g. , nonorganic implant device cardiac pacemaker infusion pump metallic implant , object body piercings remove , history welder metal worker due small metal fragment eye ) history clinically significant medical disorder epilepsy , liver kidney disease , could potentially increase risk CNS damage due manganese exposure major lab abnormality , include clinically significant abnormal range value AST , ALT , bilirubin , alkaline phosphatase , BUN , creatinine previous presumed occupational exposure manganese ( i.e. , work mine , foundry , smelter , dry cell battery manufacturing facility , agriculture ) allergy manganese ongoing treatment calciumchannel blocker irondeficiency anemia Gadolinium enhance MRI component specific exclusion : Estimated GFR &gt; 60 , test within 1 week scan allergy gadolinium</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 12, 2016</verification_date>
	<keyword>MRI</keyword>
	<keyword>Manganese Enhanced MRI</keyword>
	<keyword>Seizure Disorder</keyword>
	<keyword>Seizures</keyword>
	<keyword>Epileptic Focus</keyword>
</DOC>